Insulet | الدائنين التجاريين



Trade Creditors تغيير تاريخ
Abbott USD 11.7B 8.8B 2024-12
Align Technology USD 108.69M 342K 2024-12
AtriCure USD 25.03M 6.7M 2024-12
Avanos Medical USD 54.3M 100K 2024-12
Baxter International USD 968M 127M 2024-12
Becton, Dickinson and Co. USD 1.9B 255M 2024-09
Boston Scientific USD 960M 53M 2024-12
Cardinal Health USD 31.3B 933M 2024-12
Cooper Companies USD 201.5M 59M 2025-01
Dexcom USD 345.3M 18.7M 2024-12
Edwards Lifesciences USD 197.4M 24.6M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Globus Medical USD 75.12M 17.58M 2024-12
ICU Medical USD 148.02M 20.54M 2024-12
Insulet USD 19.8M 20.5M 2024-12
Integra LifeSciences USD 82.5M 4.84M 2024-12
J&J USD 10.31B 1.36B 2024-12
Masimo USD 252.8M 28M 2024-12
Medtronic USD 2.29B 90M 2025-01
Merit Medical Systems USD 68.5M 7.69M 2024-12
Roche Holding 4.35B 828M 2024-12
Solventum Corp 618M 58M 2024-12
Stryker USD 1.68B 342M 2024-12
Tandem Diabetes Care USD 44.73M 4.02M 2024-12
Teleflex USD 141.03M 21.78M 2024-12
West Pharmaceutical Services USD 239.3M 15M 2024-12
Zimmer Biomet Holdings USD 194.6M 127.8M 2024-12



Insulet الدائنين التجاريين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.